Bradley J. Kolls

Increased Spontaneous Unit Activity and Appearance of Spontaneous Negative Potentials in the Goldfish Tectum during Refinement of the Optic Projection

R. L. Meyer, B. Kolls, R. Meyer, 2000, The Journal of Neuroscience.

Randomized trial of lacosamide versus fosphenytoin for nonconvulsive seizures

S. Sinha, J. Halford, M. Westover, 2018, Annals of neurology.

Factor XIII deficiency mistaken for battered child syndrome: Case of “correct” test ordering negated by a commonly accepted qualitative test with limited negative predictive value

R. Dietrich, B. Kolls, R. Newman, 2002, American journal of hematology.

Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not on Statin Therapy: The ODYSSEY CHOICE II Study

Jennifer G. Robinson, J. D. Jordan, G. Molenberghs, 2016, Journal of the American Heart Association.

Transiently achieved very low low-density lipoprotein cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction: the ODYSSEY OUTCOMES trial

Pedro F. Campos, Luciano Lopes de Sousa, Howard D. Rubenstein, 2023, European heart journal.

Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation

H. Huikuri, H. Suryapranata, A. Bagai, 2024, European heart journal. Cardiovascular pharmacotherapy.